In this sense, cannabinoid receptor 1 (CNR1), which was found to be one of the common effector proteins with the three NAFLD analysed motives, presented an activation value lower than 0.1, and it is for this reason that we stop taking this protein into account from now on. The gene discussed is CNR1; the disease is metabolic dysfunction-associated steatotic liver disease.